Ubs Group Ag Checkpoint Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$1.02 - $10.6 $9,207 - $95,686
9,027 Added 41.62%
30,717 $32,000
Q2 2022

Aug 10, 2022
BUY
$0.97 - $1.77 $3,099 - $5,655
3,195 Added 17.27%
21,690 $22,000
Q1 2022

May 16, 2022
SELL
$1.53 - $3.25 $9,646 - $20,491
-6,305 Reduced 25.42%
18,495 $33,000
Q4 2021

Feb 14, 2022
SELL
$2.68 - $4.46 $30,259 - $50,357
-11,291 Reduced 31.28%
24,800 $77,000
Q3 2021

Nov 15, 2021
BUY
$2.5 - $3.53 $5,852 - $8,263
2,341 Added 6.94%
36,091 $119,000
Q2 2021

Aug 13, 2021
SELL
$2.36 - $3.2 $34,406 - $46,652
-14,579 Reduced 30.17%
33,750 $100,000
Q1 2021

May 12, 2021
BUY
$2.6 - $4.16 $99,130 - $158,608
38,127 Added 373.72%
48,329 $152,000
Q4 2020

Feb 11, 2021
BUY
$2.19 - $2.96 $21,755 - $29,404
9,934 Added 3706.72%
10,202 $27,000
Q3 2020

Nov 12, 2020
SELL
$1.62 - $4.24 $27,384 - $71,672
-16,904 Reduced 98.44%
268 $1,000
Q2 2020

Jul 31, 2020
SELL
$1.19 - $2.27 $17,388 - $33,169
-14,612 Reduced 45.97%
17,172 $34,000
Q1 2020

May 01, 2020
BUY
$1.11 - $2.43 $1,530 - $3,350
1,379 Added 4.54%
31,784 $48,000
Q4 2019

Feb 14, 2020
BUY
$1.18 - $2.39 $13,607 - $27,561
11,532 Added 61.1%
30,405 $52,000
Q3 2019

Nov 14, 2019
BUY
$2.15 - $3.36 $31,637 - $49,442
14,715 Added 353.9%
18,873 $47,000
Q2 2019

Aug 14, 2019
BUY
$2.75 - $5.0 $9,127 - $16,595
3,319 Added 395.59%
4,158 $13,000
Q1 2019

May 14, 2019
BUY
$2.01 - $4.01 $1,686 - $3,364
839 New
839 $2,000
Q2 2018

Aug 14, 2018
SELL
$2.45 - $4.39 $788 - $1,413
-322 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$3.24 - $5.6 $1,678 - $2,900
-518 Reduced 61.67%
322 $1,000
Q4 2017

Feb 14, 2018
BUY
$3.46 - $8.2 $103 - $245
30 Added 3.7%
840 $3,000
Q3 2017

Nov 14, 2017
SELL
$7.12 - $9.0 $4,200 - $5,310
-590 Reduced 42.14%
810 $7,000
Q2 2017

Aug 14, 2017
BUY
N/A
1,400
1,400 $14,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $245M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email